The US-based RAZOR (Randomised Open versus Robotic Cystectomy) trial revealed that robotic surgery is equally effective as traditional open surgery in order to treat bladder cancer. The study was funded by the National Cancer Institute and the discovery was published in the Lancet.
EchoNous announced that it has been granted FDA 510(k) clearance for its EchoNous Vein ultrasound device which could improve peripheral IV catheter placements. This system could provide real-time clear mages of superficial and deeper veins.
The U.S. Food and Drug Administration approved the first autonomous artificial intelligence diagnostic system, IDx-DR and the University of Iowa Healthcare has become the first healthcare organization to implement it.
Autoimmune hepatitis is a chronic disease more commonly seen in females, where the human body’s immune system goes awry and attacks its healthy liver cells. This immune response causes hepatitis i.e. inflammation of the liver. If left untreated, this disease can result in complications such as cirrhosis of the liver and/or hepatic failure.
Bristol-Myers Squibb’s recent immunotherapy combo won FDA approval for patients with a rare colon cancer. The combinational medicine was formulated between an older medicine named Yervoy and a new cancer-fighter Opdivo. This combo drug focuses on repairing the mismatch gene.
Onychomycosis is a fungal infection that causes nail disfigurement, pain and infection and impacts millions of people throughout the world. Though several antifungal treatments are currently available, they often fail for various reasons.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.